AXQ Capital LP purchased a new stake in CME Group Inc. (NASDAQ:CME - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 15,350 shares of the financial services provider's stock, valued at approximately $3,390,000.
Other large investors have also recently bought and sold shares of the company. Whipplewood Advisors LLC grew its holdings in CME Group by 2,075.0% in the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider's stock valued at $26,000 after buying an additional 83 shares in the last quarter. Elkhorn Partners Limited Partnership acquired a new stake in shares of CME Group during the fourth quarter worth $27,000. Hilton Head Capital Partners LLC bought a new stake in shares of CME Group in the fourth quarter valued at about $28,000. Mowery & Schoenfeld Wealth Management LLC bought a new stake in shares of CME Group in the second quarter valued at about $28,000. Finally, Legacy Wealth Managment LLC ID boosted its position in shares of CME Group by 191.9% in the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider's stock valued at $29,000 after acquiring an additional 71 shares during the period. 87.75% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of research analysts have issued reports on the stock. JPMorgan Chase & Co. increased their target price on shares of CME Group from $249.00 to $250.00 and gave the stock an "underweight" rating in a research report on Thursday, July 23rd. Bank of America upped their price target on shares of CME Group from $226.00 to $230.00 and gave the stock an "underperform" rating in a report on Thursday, July 23rd. Morgan Stanley increased their price target on shares of CME Group from $324.00 to $330.00 and gave the stock an "overweight" rating in a research report on Thursday, July 23rd. Piper Sandler decreased their price objective on shares of CME Group from $329.00 to $295.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 15th. Finally, Keefe, Bruyette & Woods upgraded shares of CME Group from a "market perform" rating to an "outperform" rating and set a $305.00 price objective for the company in a research report on Thursday, June 18th. Nine research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $289.75.
Read Our Latest Research Report on CME
CME Group Stock Performance
NASDAQ:CME opened at $282.05 on Friday. The stock has a market cap of $101.42 billion, a P/E ratio of 23.92, a price-to-earnings-growth ratio of 3.28 and a beta of 0.24. The stock's 50-day moving average is $257.55 and its 200-day moving average is $278.36. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16.
CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.08. The company had revenue of $1.71 billion for the quarter, compared to analysts' expectations of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. CME Group's revenue for the quarter was up .8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.96 earnings per share. Equities research analysts anticipate that CME Group Inc. will post 12.27 earnings per share for the current year.
CME Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be paid a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group's dividend payout ratio (DPR) is currently 44.11%.
Insiders Place Their Bets
In other news, Director William Shepard bought 325 shares of the company's stock in a transaction that occurred on Thursday, June 25th. The shares were acquired at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the acquisition, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.30% of the stock is owned by corporate insiders.
About CME Group
(
Free Report)
CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Articles
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
